Callisia N. Clarke, MD, MS, FACS, FSSO

Associate Professor and Chief

Request an Appointment

Location

Cancer Center - Froedtert Hospital
8800 West Doyne Ave.
Milwaukee, WI 53226

Specialties

Surgical Oncology

Established Patient Appointments

(414) 955-1434

New Patient Appointments

(414) 805-6849

Overview

Diseases and Conditions

Melanoma
Neuroendocrine Tumors
Pancreatic Cancer
Sarcoma
Benign Pancreatic Disease

Treatments and Services

Limb and Liver Perfusion
Virtual Visit
Primary and Metastatic Neuroendocrine Tumors

Patients Ages Seen

Adult
Senior

Languages

English

Hospital Affiliations

Froedtert Hospital – Milwaukee
Children's Wisconsin - Milwaukee – Milwaukee

Board Certifications

Surgery
Complex General Surgical Oncology

Clinic Locations

Cancer Center - Froedtert Hospital

8800 West Doyne Ave.
Milwaukee, WI 53226
(866) 680-0505
Get Directions

Biography

Dr. Clarke specializes in Surgical Oncology with a focus on tumors of the upper gastrointestinal tract, sarcomas, melanomas and regional therapies for advanced malignancies.

Her research interests are centered on personalized cancer care and targeted approaches in Pancreatic Neuroendocrine Tumors.

Education and Training

Doctor of Medicine - University of Cincinnati College of Medicine - Cincinnati, OH (2006)
General Surgery Residency - University of Cincinnati - Cincinnati, OH (2013)
Complex General Surgical Oncology Fellowship - University of Texas M. D. Anderson Cancer Center - Houston, TX (2016)

Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy.

(Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK.) Surgery. 2024 May;175(5):1386-1393 PMID: 38413302 SCOPUS ID: 2-s2.0-85186348752 02/28/2024
Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases.

(Bello RJ, Clarke CN.) Ann Surg Oncol. 2024 Apr;31(4):2192-2193 PMID: 38273173 SCOPUS ID: 2-s2.0-85183621978 01/26/2024
ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms.

(Hallet J, Clarke CN.) Ann Surg Oncol. 2024 Mar;31(3):1704-1713 PMID: 38167813 SCOPUS ID: 2-s2.0-85181198604 01/04/2024
Live to fight another day: Combining parenchymal sparing resection and ablative therapy in neuroendocrine tumor liver metastases.

(Bello RJ, Clarke CN.) Am J Surg. 2024 Mar;229:15-16 PMID: 37985321 SCOPUS ID: 2-s2.0-85178186495 11/21/2023
Can I Leave? Perspectives on Parental Leave and Parenthood in Medical Training Among Program Directors and Trainees in Oncologic Specialties.

(Beltrán Ponce S, Jagsi R, Florez N, Thomas CR Jr, Banerjee A, Jasti S, Bailey MM, Lawton CAF, Johnstone C, Clarke CN, Bedi M, Jovanovic M, Saeed H.) J Womens Health (Larchmt). 2024 Feb;33(2):218-227 PMID: 38011014 SCOPUS ID: 2-s2.0-85179389889 11/27/2023
ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms

(Hallet J, Clarke CN.) Annals of Surgical Oncology. March 2024;31(3):1704-1713 SCOPUS ID: 2-s2.0-85181198604 03/01/2024
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy.

(Florissi I, Radomski SN, Shou B, Cloyd JM, Kim A, Grotz T, Fournier K, Baumgartner JM, Lambert L, Abbott DE, Schwartz P, Staley CA, Clarke C, Dineen S, Patel SH, Wilson GC, Raoof M, Johnston FM, Greer JB.) J Surg Res. 2024 Jan;293:403-412 PMID: 37806228 SCOPUS ID: 2-s2.0-85173471313 10/09/2023
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

(de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA.) Cancer Med. 2023 Dec 22;13(1) PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023
ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.

(Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB.) Ann Surg Oncol. 2023 Dec;30(13):8178-8179 PMID: 37768415 SCOPUS ID: 2-s2.0-85176495252 09/28/2023
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.

(Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB.) Ann Surg Oncol. 2023 Nov;30(12):7840-7847 PMID: 37620532 PMCID: PMC10592201 SCOPUS ID: 2-s2.0-85168622027 08/25/2023
Integration of the social determinants of health into quality indicators for colorectal cancer surgery: a scoping review protocol.

(Bondzi-Simpson A, Ribeiro T, Benipal H, Barabash V, Lofters A, Sutradhar R, Snyder RA, Clarke C, Coburn NG, Hallet J.) BMJ Open. 2023 Sep 26;13(9):e075270 PMID: 37751959 PMCID: PMC10533733 SCOPUS ID: 2-s2.0-85174022015 09/29/2023
Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors.

(Clarke CN, Cockrum P, Beveridge TJR, Jerry M, McMorrow D, Tran AT, Phan AT.) J Health Econ Outcomes Res. 2023;10(2):121-131 PMID: 38093906 PMCID: PMC10718524 12/14/2023